Dr. Dan P. Sipple
Dr. Daniel Sipple is board certified in physical medicine and rehabilitation with sub-specialty board certification in pain medicine. He trained at the Rehabilitation Institute of Chicago, now the Shirley Ryan Ability Lab, the #1 rated rehabilitation hospital in US News and World Report for over 20 years running. He served on the faculty at Northwestern University Medical School while working at RIC’s American Academy of Pain Medicine Center of Excellence. He subsequently practiced in Denver Colorado for two years, working alongside former team physicians of the Denver Broncos and Colorado Rockies. Thereafter, at the Mayo Clinic in Eau Claire, Wisconsin via the Pain Clinic of NW Wisconsin. He served as the medical director of the Health East Spine Center, and service line medical director over Neurosurgery, Behavioral Health, Pain, and Spine for the health system. He presently practices at Midwest Spine and Brain Institute.
Dr. Sipple is the co-founder of InSitu Biologics, and co-inventor of INSB 200, a sustained-release non-opiate pain killer for post-operative pain set to enter phase I FDA clinical trials in 2022. He is the patient holder in safe needle technology and the founder of Acies Medical. He served on the Board of Directors for the Society for Brain Mapping and Therapeutics, a NASA Spinout, and part of President Obama’s BRAIN Initiative. In that capacity has presented to the United States Congress, the California Legislature, and the White House, along with world leaders at the Neuroscience 20 Summit in conjunction with the G20 in Buenos Aires, Argentina, and Osaka Japan.
SBMT think tank papers that Dr. Sipple has co-authored have been recognized by the WHO, including a leading position paper on COVID-19. SBMT’s Brain Technology Park Initiative seeks to place the United States as a global leader in neurotech, and is supported by DARPA, NASA, Los Alamos National Labs, Lawerence Livermore National Labs, et al. Dr. Sipple’s learned inventing from his father, Ralph Edward Sipple, a farm-raised engineer, and holder of 18 patents, including video on demand.
James W. Bracke, PhD.
Dr. Bracke is a member of the Boards of Autoscope Technologies Corporation (since 2009), and NVE Corporation (since 2021). He was Vice President of Oral Health and EPIEN Medical Inc., a privately held medical device company, from 2014-2018. He has been President of Boulder Creek Consulting, LLC, a business and technology consulting firm, since 2004. Mr. Bracke was previously a director of Enventis Corporation, formerly known as Hickory Tech Corporation from 2004 until it was acquired by Consolidated Communications Holdings, Inc. in October 2014. He was also a member of the Board of Lifecore Biomedical Inc from 1983 to 2004. He was Managing Director of National Green Gas LLC, a medical waste-to-energy company, from 2009 to 2014. Mr. Bracke has extensive management, technical and public company experiences, including 20 years as co-founder, President, and Chief Executive Officer of Lifecore Biomedical, Inc., a medical device manufacturer, from 1983 to 2004. He holds two international patents.
Brian L. Norling
CTO Acies Biomedical
Brian Norling is an experienced executive in engineering management. He has over thirty-five years of experience in managing large teams of engineers, scientists and technicians. He has been Director of Engineering for Sundstrand Data Control and Litton Guidance & Control with a team of 210 technical staff. He was Vice President of Engineering for Taltec, a robotics company. He is CEO for MEMS Precision Technology Inc. and President of Innovative Solutions, a high technology engineering consulting organization.
He is be a big picture thinker and have a very broad background in mechanical engineering, electrical engineering, physics, chemical engineering, software engineering and model-based design. He also has a Master’s in Business Administration from Seattle University with Beta Gamma Sigma national honors. He graduated from the Battelle Memorial Institute’s VP/GM executive leadership training program. He also attended classes at Massachusetts Institute of Technology for Micromachined Electro-Mechanical System (MEMS/nano) design. His creativity is highlighted by the award of over fifty-five patents. He has published approximately twenty technical papers.
Brian has led many biomedical device development efforts including a foot pressure sequence recording and alert device for diabetic patients with peripheral neuropathy, a wireless MEMS brain and ocular hypertension pressure measurement device, the Acies Smart Needle for sensing the presence or absence of arterial blood, an ultrasonic needle for the selective removal of calcified abnormalities in the body, a generic MEMS chemical/biological sensing platform with 10-8 gram sensing threshold, and a novel brain electrode with nano-needle augmentation.
He proven track record at the executive management level, ranging from startup operations to large aerospace engineering team management. He has taken many products from the creation stage to full profitable commercialization. He has extensive experience in market analysis and new business development and has been involved in many mergers, acquisitions, divestitures and technology commercialization. He led the development of highly complex technology systems such as guidance, navigation and control systems, robotic semiconductor manufacturing equipment, integrated digital avionics systems (glass cockpits) for fixed and rotary wing aircraft, spacecraft attitude control systems, launch vehicle guidance, and GPS/INS navigation systems. He is also experienced in the design and development of precision sensor systems such as gyros, accelerometers, biomedical sensors, chemical sensors, pressure sensors, fiber optic alignment systems, and mass sensors.
Brian is on the Science Advisory Board for the International Society for Brain Mapping & Therapeutics and is Track Chairman for the Psychiatry/Addiction track of the SBMT Annual World Congress with sixty presentations in the track, most of which are accredited for Continuing Medical Education credits.